Company Profile
Viridian Therapeutics Stock Price, News & Analysis
- Ticker:
- VRDN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
18.56 USD (+16.95%)
Close
Last updated: July 20, 2026
1.75B USD
Market cap
Why the stock is moving
VRDN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Viridian Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Viridian Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Viridian Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Viridian Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
BMY · Source: BMYBristol-Myers Squibb Company
- 03
- 04
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
FMS · Source: Fresenius Medical Care Ventures
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Viridian Therapeutics (VRDN)?
Viridian Therapeutics (VRDN) most recently closed at 18.56 USD, a +16.95% move versus the previous session.
What is the market cap of Viridian Therapeutics (VRDN)?
Viridian Therapeutics currently has a market capitalization of 1.75B USD on BioPharmSignal.
What does Viridian Therapeutics do?
Viridian Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is VRDN stock listed?
Viridian Therapeutics (VRDN) is associated with NASDAQ, United States, Biotechnology.
What is Viridian?
Viridian Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Viridian Therapeutics targeting with Viridian?
Viridian Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Viridian Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.